Literature DB >> 1653963

Vascular activities of the endothelins.

M D Randall1.   

Abstract

The endothelins are a family of novel 21 amino-acid peptides and are the most potent vasoconstrictor substances yet discovered. The endothelins not only produce prolonged pressor responses in intact animals but they also constrict large and small arterial and venous vessels studied as isolated vascular preparations, influence autonomic transmission, exert positive inotropic effects on the heart and have been shown to be capable of releasing EDRF, prostanoids and atrial natriuretic factor. Release of endothelins occurs after de novo synthesis which may be stimulated by various agonists, fluid-flow and possibly hypoxia. The endothelins have been implicated in the pathophysiology of a variety of cardiovascular disorders but their precise role remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653963     DOI: 10.1016/0163-7258(91)90073-u

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  11 in total

1.  Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Authors:  J Petersson; G C Hanson; B F Lindberg; E D Högestätt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury.

Authors:  R Ricciardi; B K Schaffer; S A Shah; S H Quarfordt; B F Banner; S M Wheeler; S E Donohue; W C Meyers; R S Chari
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

3.  Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.

Authors:  D M Lanese; J D Conger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.

Authors:  G G Mattera; A Eglezos; A R Renzetti; J Mizrahi
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.

Authors:  L McMurdo; R Corder; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

6.  [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.

Authors:  Michael Zimmermann; Carla Sabine Jung; Hartmut Vatter; Andreas Raabe; Volker Seifert
Journal:  Neurosurg Rev       Date:  2002-11-19       Impact factor: 3.042

7.  Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery.

Authors:  V J Harrison; A Randriantsoa; P Schoeffter
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

8.  Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

9.  Effects of endothelin receptor antagonists on bradykinin-induced increases in macromolecular efflux.

Authors:  W G Mayhan; I Rubinstein
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

10.  Modulatory effects of endothelin-1 on purinergic and adrenergic components of sympathetically-mediated contractile activity of rabbit saphenous artery.

Authors:  V N Mutafova-Yambolieva; R G Radomirov
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.